IL2 and infection: These matched patients from two groups had comparable characteristics except for the incidence of infections, with a lower incidence of infection in IL-2 group as compared to non-IL-2 group (8.3%, 15/181 v.s. 33.7%, 61/181, P-value < 0.001) (Fig 1D).